The results of this study show that Escin significantly decreased the growth of human pancreatic carcinoma cells, inhibited NF-κB signaling pathways, and sensitized pancreatic cancer cells to the cytotoxic effect of chemotherapy. The gene discussed is NFKB1; the disease is exocrine pancreatic carcinoma.